{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:19:46Z","timestamp":1790990386100,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,22]]},"DOI":"10.7759\/cureus.11617","type":"journal-article","created":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T10:46:03Z","timestamp":1606041963000},"source":"Crossref","is-referenced-by-count":10,"title":["A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Jasndeep","family":"Kaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayema","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundip","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Prostate Cancer Statistics. (2020). Accessed. August 30, 2020: https:\/\/www.cdc.gov\/cancer\/prostate\/statistics\/index.htm."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin MS","year":"2017","unstructured":"Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017, 317:2532-2542. 10.1001\/jama.2017.7248","journal-title":"JAMA"},{"key":"ref3","unstructured":"What is Prostate Cancer?. (2018). Accessed. August 30, 2020: https:\/\/www.urologyhealth.org\/urologic-conditions\/prostate-cancer."},{"key":"ref4","article-title":"Active surveillance of prostate cancer","volume":"31","author":"Choyke PL","year":"2017","unstructured":"Choyke PL, Loeb S. Active surveillance of prostate cancer. Oncology (Williston Park, NY). 2017, 31:67.","journal-title":"Oncology (Williston Park, NY)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.10.013","article-title":"Epidemiology of prostate cancer","volume":"62","author":"Crawford ED","year":"2003","unstructured":"Crawford ED. Epidemiology of prostate cancer. Urology. 2003, 62:3-12. 10.1016\/j.urology.2003.10.013","journal-title":"Urology"},{"key":"ref6","article-title":"Prostate Cancer","author":"Leslie SW","year":"2020","unstructured":"Leslie SW, Soon-Sutton TL, Sajjad H, et al.. Prostate Cancer. StatPearls, Treasure Island, FL; 2020."},{"key":"ref7","article-title":"Cancer Prostate Screening","author":"Jain M. A.","year":"2020","unstructured":"Jain M. A., Sapra A. Cancer Prostate Screening. StatPearls, Treasure Island, FL; 2020."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.17925\/OHR.2005.00.00.1f","article-title":"Epidemiology of prostate cancer","volume":"1","author":"Kumar RJ","year":"2005","unstructured":"Kumar RJ, Barqawi AB, Crawford ED. Epidemiology of prostate cancer. US Oncol Rev. 2005, 1:1-6. 10.17925\/OHR.2005.00.00.1f","journal-title":"US Oncol Rev"},{"key":"ref9","article-title":"Anatomy, Abdomen and Pelvis, Prostate","author":"Singh O","year":"2019","unstructured":"Singh O, Bolla S. R. Anatomy, Abdomen and Pelvis, Prostate. StatPearls, Treasure Island, FL; 2019."},{"key":"ref10","article-title":"Types of Prostate Cancer","author":"Hribar C","year":"2020","unstructured":"Hribar C. Types of Prostate Cancer. 2020."},{"key":"ref11","article-title":"Types of Prostate Cancer","author":"Durning MV","year":"2020","unstructured":"Durning MV. Types of Prostate Cancer. 2020."},{"key":"ref12","article-title":"Risk factors for prostate cancer","volume":"4","author":"Gann PH","year":"2002","unstructured":"Gann PH. Risk factors for prostate cancer. Rev Urol. 2002, 4:S3-S10.","journal-title":"Rev Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0234-y","article-title":"Nutrition, dietary interventions and prostate cancer: the latest evidence","volume":"13","author":"Lin PH","year":"2015","unstructured":"Lin PH, Aronson W, Freedland SJ. Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med. 2015, 13:3. 10.1186\/s12916-014-0234-y","journal-title":"BMC Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.106450","article-title":"Are strict vegetarians protected against prostate cancer?","volume":"103","author":"Tantamango-Bartley Y","year":"2016","unstructured":"Tantamango-Bartley Y, Knutsen SF, Knutsen R, Jacobsen BK, Fan J, Beeson WL, Herring P. Are strict vegetarians protected against prostate cancer?. Am J Clin Nutr. 2016, 103:153-160. 10.3945\/ajcn.114.106450","journal-title":"Am J Clin Nutr"},{"key":"ref15","unstructured":"What is Prostate Cancer?. (2018). Accessed. August 30, 2020: https:\/\/www.urologyhealth.org\/urologic-conditions\/prostate-cancer."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13417","article-title":"Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate\u2010specific antigen (PSA) level: a meta\u2010analysis","volume":"118","author":"Boyle P","year":"2016","unstructured":"Boyle P, Koechlin A, Bota M, et al.. Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate\u2010specific antigen (PSA) level: a meta\u2010analysis. BJU Int. 2016, 118:731-741. 10.1111\/bju.13417","journal-title":"BJU Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.06.005","article-title":"Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly","volume":"66","author":"Bhindi B","year":"2014","unstructured":"Bhindi B, Kulkarni G. S, Finelli A, et al.. Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly. Eur Urol. 2014, 66:841-848. 10.1016\/j.eururo.2014.06.005","journal-title":"Eur Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4472","article-title":"Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins","volume":"66","author":"Xu Y","year":"2006","unstructured":"Xu Y, Chen SY, Ross KN, et al.. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res. 2006, 66:7783-7792. 10.1158\/0008-5472.CAN-05-4472","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.06001","article-title":"AR, the cell cycle, and prostate cancer","volume":"6","author":"Balk SP","year":"2008","unstructured":"Balk SP, Knudsen KE. AR, the cell cycle, and prostate cancer. Nuclear Receptor Signaling. 2008, 6:06001. 10.1621\/nrs.06001","journal-title":"Nuclear Receptor Signaling"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.06.033","article-title":"The AR dependent cell cycle: mechanisms and cancer relevance","volume":"352","author":"Schiewer MJ","year":"2012","unstructured":"Schiewer MJ, Augello MA, Knudsen KE. The AR dependent cell cycle: mechanisms and cancer relevance. Mol Cellular Endocrinol. 2012, 352:34-45. 10.1016\/j.mce.2011.06.033","journal-title":"Mol Cellular Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/medsci8030028","article-title":"Epidemiology, staging and management of prostate cancer","volume":"8","author":"Barsouk A","year":"2020","unstructured":"Barsouk A, Padala SA, Vakiti A, et al.. Epidemiology, staging and management of prostate cancer. Med Sci. 2020, 8:28. 10.3390\/medsci8030028","journal-title":"Med Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.879","article-title":"Smoking and prostate cancer survival and recurrence","volume":"305","author":"Kenfield SA","year":"2011","unstructured":"Kenfield SA, Stampfer MJ, Chan JM, et al.. Smoking and prostate cancer survival and recurrence. JAMA. 2011, 305:2548-2555. 10.1001\/jama.2011.879","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.03.054","article-title":"Obesity and prostate cancer: a role for adipokines","volume":"52","author":"Mistry T","year":"2007","unstructured":"Mistry T, Digby JE, Desai KM, et al.. Obesity and prostate cancer: a role for adipokines. Eur Urol. 2007, 52:46-53. 10.1016\/j.eururo.2007.03.054","journal-title":"Eur Urol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603030","article-title":"Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs","volume":"94","author":"Brown MD","year":"2006","unstructured":"Brown MD, Hart CA, Gazi E, et al.. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer. 2006, 94:842-853. 10.1038\/sj.bjc.6603030","journal-title":"Br J Cancer"},{"key":"ref25","unstructured":"Prostate Cancer. (2020). Accessed. September 02, 2020: https:\/\/emedicine.medscape.com\/article\/1967731-overview."},{"key":"ref26","article-title":"Prostate Specific Antigen (PSA)","author":"David MK","year":"2020","unstructured":"David MK, Leslie SW. Prostate Specific Antigen (PSA). StatPearls, Treasure Island, FL; 2020."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2017.12.002","article-title":"Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: a UK case study","volume":"52","author":"Leal J","year":"2018","unstructured":"Leal J, Welton N.J, Martin RM, et al.. Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: a UK case study. Cancer Epidemiol. 2018, 52:99-105. 10.1016\/j.canep.2017.12.002","journal-title":"Cancer Epidemiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990120105","article-title":"Three predominant proteins secreted by the human prostate gland","volume":"12","author":"Lilja H","year":"1988","unstructured":"Lilja H, Abrahamsson PA. Three predominant proteins secreted by the human prostate gland. Prostate. 1988, 12:29-38. 10.1002\/pros.2990120105","journal-title":"Prostate"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.9406","article-title":"Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey","volume":"28","author":"Chang SL","year":"2010","unstructured":"Chang SL, Harshman LC, Presti Jr JC. Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey. J Clin Oncol. 2010, 28:3951-3957. 10.1200\/JCO.2009.27.9406","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4111\/icu.2017.58.5.365","article-title":"\u201cTargeted\u201d prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy","volume":"58","author":"Singh P","year":"2017","unstructured":"Singh P, Kumar A, Yadav S, et al.. \u201cTargeted\u201d prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy. Investigative Clin Urol. 2017, 58:365-370. 10.4111\/icu.2017.58.5.365","journal-title":"Investigative Clin Urol"},{"key":"ref31","article-title":"Gleason Score","author":"Munjal A","year":"2020","unstructured":"Munjal A, Leslie SW.. Gleason Score. StatPearls, Treasure Island, FL; 2020."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-016-0478-2","article-title":"Grading of prostatic adenocarcinoma: current state and prognostic implications","volume":"11","author":"Gordetsky J","year":"2016","unstructured":"Gordetsky J, Epstein J. Grading of prostatic adenocarcinoma: current state and prognostic implications. Diagn Pathol. 2016, 11:25. 10.1186\/s13000-016-0478-2","journal-title":"Diagn Pathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.1278","article-title":"Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression","volume":"84","author":"Taneja SS","year":"2002","unstructured":"Taneja SS, Ha S, Garabedian MJ. Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression. J Cellular Biochem. 2002, 84:188-200. 10.1002\/jcb.1278","journal-title":"J Cellular Biochem"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi N","year":"2005","unstructured":"Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA. 2005, 294:238-244. 10.1001\/jama.294.2.238","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.10.4.709","article-title":"LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action","volume":"10","author":"Limonta P","year":"2001","unstructured":"Limonta P, Marelli, MM, Moretti RM. LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action. Expert Opinion Investigational Drugs. 2001, 10:709-720. 10.1517\/13543784.10.4.709","journal-title":"Expert Opinion Investigational Drugs"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01581-9","article-title":"Secondary hormonal therapies in the treatment of prostate cancer","volume":"60","author":"William KO","year":"2002","unstructured":"William KO. Secondary hormonal therapies in the treatment of prostate cancer. Urology. 2002, 60:87-92. 10.1016\/S0090-4295(02)01581-9","journal-title":"Urology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes","volume":"331","author":"Loprinzi CL","year":"1994","unstructured":"Loprinzi CL, Michalak JC, Quella SK, et al.. Megestrol acetate for the prevention of hot flashes. New Engl J Med. 1994, 331:347-352. 10.1056\/NEJM199408113310602","journal-title":"New Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199904000-00013","article-title":"Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes","volume":"92","author":"Sartor O","year":"1999","unstructured":"Sartor O, Eastham JA. Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes. Southern Med J. 1999, 92:415-416. 10.1097\/00007611-199904000-00013","journal-title":"Southern Med J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2004.01.001","article-title":"Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician","volume":"31","author":"Higano CS","year":"2004","unstructured":"Higano CS. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician. Urol Clin. 2004, 31:331-352. 10.1016\/j.ucl.2004.01.001","journal-title":"Urol Clin"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10656","article-title":"The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma","volume":"95","author":"Fowler Jr","year":"2002","unstructured":"Fowler Jr, F J, McNaughton CM, et al.. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma. Cancer. 2002, 95:287-295. 10.1002\/cncr.10656","journal-title":"Cancer"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00234.x","article-title":"Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade","volume":"79","author":"Strum SB","year":"1997","unstructured":"Strum SB, McDermed JE, Scholz MC, et al.. Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. British journal of urology. 1997, 79:933-941. 10.1046\/j.1464-410X.1997.00234.x","journal-title":"British journal of urology"},{"key":"ref42","article-title":"Urology, an Issue of Medical Clinics of North America","author":"Brannigan RE","year":"2018","unstructured":"Brannigan RE. Urology, an Issue of Medical Clinics of North America. Elsevier, Amsterdam; 2018."},{"key":"ref43","unstructured":"Radical Prostatectomy. (2020). Accessed. September 05, 2020: https:\/\/www.hopkinsmedicine.org\/health\/treatment-tests-and-therapies\/radical-prostatectomy."},{"key":"ref44","unstructured":"Surgery for Prostate Cancer. (2019). Accessed. September 05, 2020: https:\/\/www.cancer.org\/cancer\/prostate-cancer\/treating\/surgery.html."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2012.04.art2","article-title":"Radical perineal prostatectomy-the contemporary resurgence of a genuinely minimally invasive procedure: Procedure outline. Comparison of the advantages, disadvantages, and outcomes of different surgical techniques of treating organ-confined prostate cancer (PCa). A literature review with special focus on perineal prostatectomy","volume":"65","author":"Wro\u0144ski S","year":"2012","unstructured":"Wro\u0144ski S. Radical perineal prostatectomy-the contemporary resurgence of a genuinely minimally invasive procedure: Procedure outline. Comparison of the advantages, disadvantages, and outcomes of different surgical techniques of treating organ-confined prostate cancer (PCa). A literature review with special focus on perineal prostatectomy. Central Eur J Urol. 2012, 65:188. 10.5173\/ceju.2012.04.art2","journal-title":"Central Eur J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45459-a-comprehensive-review-of-pharmaceutical-and-surgical-interventions-of-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:04Z","timestamp":1707506644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45459-a-comprehensive-review-of-pharmaceutical-and-surgical-interventions-of-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,22]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.11617","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,22]]}}}